ADBIC
DGX icon

A.D. Beadell Investment Counsel’s Quest Diagnostics DGX Stock Holding History

A.D. Beadell Investment Counsel’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,545
Closed -$348K – 89
2017
Q1 		$348K Sell
3,545
-6,025
-63% -$574K 0.29% 74
2016
Q4 		$879K Hold
9,570
– – 0.75% 47
2016
Q3 		$809K Hold
9,570
– – 0.67% 55
2016
Q2 		$779K Hold
9,570
– – 0.64% 57
2016
Q1 		$683K Buy
9,570
+125
+1% +$8.38K 0.63% 56
2015
Q4 		$671K Buy
9,445
+1,140
+14% +$76.6K 0.59% 59
2015
Q3 		$510K Buy
+8,305
New +$580K 0.46% 65

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

A.D. Beadell Investment Counsel's DGX Position: Q2 2017 in Review

A.D. Beadell Investment Counsel sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 3,545 shares — an estimated $348K sold.

A.D. Beadell Investment Counsel first reported a position in DGX in Q3 2015 and held it in 7 quarters. The position peaked at $879K in Q4 2016. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • A.D. Beadell Investment Counsel reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • A.D. Beadell Investment Counsel sold 3,545 Quest Diagnostics shares in Q2 2017, an estimated $348K.
  • A.D. Beadell Investment Counsel first reported a position in Quest Diagnostics in Q3 2015 and held it in 7 quarters.
  • A.D. Beadell Investment Counsel's Quest Diagnostics position peaked at $879K in Q4 2016.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on A.D. Beadell Investment Counsel's 13F filing for Q2 2017, filed 25 Jul 2017.